...
首页> 外文期刊>Journal of proteomics >Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis.
【24h】

Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis.

机译:蛋白质组学分析晚期大肠癌的激光捕获显微切割和二维差异凝胶电泳。

获取原文
获取原文并翻译 | 示例
           

摘要

The emergence of laser capture microdissection (LCM) and two-dimensional difference gel electrophoresis (2D-DIGE) has been shown to greatly improve the accuracy and sensitivity of global protein expression analysis. However, their combined use in profiling tumour proteome has rarely been reported. In this study, we applied these techniques to profile the protein expression changes of the late stage colorectal cancer (CRC) and its liver metastases. The study revealed that both the primary and secondary tumours showed a distinct protein expression profile compared to normal tissues, but were indistinguishable from each other. Differential analysis between the primary tumour and patient-matched normal colon mucosa identified a total of 71 proteins to be altered in CRC. Over 40% of these proteins have been previously reported as CRC-related proteins, validating the accuracy of the current analysis. We have also identified many previously unknown changes including overexpression of ACY1, HSC70, HnRNP I, HnRNP A3, SET, ANP32A and TUFM in CRC, which have been further verified by western blotting and immunohistochemistry. This study demonstrated that LCM in combination with 2D-DIGE is a powerful tool to analyse the proteome of tumour tissues and may lead to the identification of potential novel protein markers and therapeutic targets for cancer.
机译:激光捕获显微切割术(LCM)和二维差异凝胶电泳(2D-DIGE)的出现已被证明可以大大提高整体蛋白质表达分析的准确性和灵敏度。然而,很少有报道将它们联合用于分析肿瘤蛋白质组。在这项研究中,我们应用这些技术来分析晚期结直肠癌(CRC)及其肝转移蛋白的蛋白表达变化。研究表明,与正常组织相比,原发性和继发性肿瘤均显示出不同的蛋白质表达谱,但彼此之间没有区别。在原发肿瘤和患者匹配的正常结肠粘膜之间进行差异分析,发现总共有71种蛋白在CRC中被改变。这些蛋白中有40%以上已被报道为CRC相关蛋白,从而验证了当前分析的准确性。我们还鉴定了许多以前未知的变化,包括ACY1,HSC70,HnRNP I,HnRNP A3,SET,ANP32A和TUFM在CRC中的过表达,这些已通过Western印迹和免疫组织化学进一步证实。这项研究表明,将LCM与2D-DIGE结合使用是分析肿瘤组织蛋白质组的强大工具,并且可能导致潜在的新型蛋白质标记物和癌症治疗靶标的鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号